Therapeutic Goods Legislation Amendment (Copyright) Act 2011

Overview

The Therapeutic Goods Legislation Amendment (Copyright) Act 2011, enacted by the Parliament of Australia, aims to address the problem of balancing copyright protection with the need for access to essential information about medicines. This legislation amends the Copyright Act 1968 to clarify that certain acts related to the supply, reproduction, publication, communication, and adaptation of approved product information for medicines do not constitute an infringement of copyright, provided these actions are for the purpose of ensuring the safe and effective use of the medicine. This amendment ensures that healthcare professionals and consumers have access to necessary information while still protecting the rights of copyright holders. The Act also includes provisions for compensation if the amendments result in the acquisition of property from a person otherwise than on just terms.

Scope and Application

The Therapeutic Goods Legislation Amendment (Copyright) Act 2011 amends the Copyright Act 1968 to provide specific exceptions to copyright infringement for certain acts relating to product information approved under the Therapeutic Goods Act 1989. This Act applies to any acts performed in relation to approved product information for medicines, including those concerning restricted medicines or medicines that are subject to specific regulatory actions under the Therapeutic Goods Act. The amendments are effective for acts done in Australia and apply to any acts performed after the Act's commencement, irrespective of when the product information was approved. The Act also includes provisions for compensation if the amendments result in the acquisition of property from a person otherwise than on just terms, as defined under the Constitution. The Act's reach is limited to Australia and does not extend beyond the boundaries of the Commonwealth, and its application is further detailed in the Schedule, which outlines the specific changes to the Copyright Act 1968.

Key Provisions

The Therapeutic Goods Legislation Amendment (Copyright) Act 2011 introduces specific amendments to the Copyright Act 1968 to address the use of product information for therapeutic goods. Section 44BA of the Copyright Act 1968, inserted by this Act, outlines that certain acts related to product information for medicine are not considered an infringement of copyright. This includes acts done under the Therapeutic Goods Act 1989 in respect of restricted medicine, medicine under specific regulatory conditions, or where certain subsections of the Therapeutic Goods Act apply (section 44BA(1)). Additionally, acts that are ancillary or incidental to these acts are also exempt from copyright infringement (section 44BA(1)(b)). Furthermore, the supply, reproduction, publication, communication, and adaptation of approved product information in Australia for purposes related to the safe and effective use of medicine are not considered infringements (section 44BA(2)). Acts ancillary or incidental to these activities are similarly protected (section 44BA(3)). The obligations imposed by this Act primarily concern the entities and individuals involved in the therapeutic goods sector. They must ensure that any actions taken with respect to product information for medicine are aligned with the exemptions provided under section 44BA. This means that these entities and individuals must verify that their activities fall within the scope of the permitted acts to avoid infringing on the copyright of the product information. This includes confirming that the activities are undertaken for the purpose of safe and effective use of the medicine, which requires a clear understanding of both the Therapeutic Goods Act 1989 and the Copyright Act 1968 as amended. For breaches of the provisions outlined in this Act, there are no explicit criminal or civil penalties stated within the text. However, the Act does include a provision for compensation if its operation results in the acquisition of property from a person otherwise than on just terms (section 44BA(4)). If the Commonwealth and the affected person cannot agree on the amount of compensation, the person may seek a court determination (section 44BA(5)). This compensation mechanism ensures that any adverse effects on property rights are addressed, although it does not constitute a punitive measure for breaches of the Act.